Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
AU508824B2 - Adminstration of 5-methyl-1-phenyl-2-(1h)-pyridone - Google Patents
[go: Go Back, main page]

AU508824B2 - Adminstration of 5-methyl-1-phenyl-2-(1h)-pyridone - Google Patents

Adminstration of 5-methyl-1-phenyl-2-(1h)-pyridone

Info

Publication number
AU508824B2
AU508824B2 AU87383/75A AU8738375A AU508824B2 AU 508824 B2 AU508824 B2 AU 508824B2 AU 87383/75 A AU87383/75 A AU 87383/75A AU 8738375 A AU8738375 A AU 8738375A AU 508824 B2 AU508824 B2 AU 508824B2
Authority
AU
Australia
Prior art keywords
adminstration
pyridone
phenyl
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU87383/75A
Other versions
AU8738375A (en
Inventor
S. M Gadekar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Affiliated Medical Research Inc
Original Assignee
AFFILIATED MED RES
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/530,684 external-priority patent/US3974281A/en
Application filed by AFFILIATED MED RES filed Critical AFFILIATED MED RES
Publication of AU8738375A publication Critical patent/AU8738375A/en
Application granted granted Critical
Publication of AU508824B2 publication Critical patent/AU508824B2/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
AU87383/75A 1974-12-09 1975-12-09 Adminstration of 5-methyl-1-phenyl-2-(1h)-pyridone Expired AU508824B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
USUS530,684 1974-12-09
US05/530,684 US3974281A (en) 1972-12-18 1974-12-09 5-Methyl-1-phenyl-2-(1H)-pyridone compositions and methods of use

Publications (2)

Publication Number Publication Date
AU8738375A AU8738375A (en) 1977-06-16
AU508824B2 true AU508824B2 (en) 1980-04-03

Family

ID=24114565

Family Applications (1)

Application Number Title Priority Date Filing Date
AU87383/75A Expired AU508824B2 (en) 1974-12-09 1975-12-09 Adminstration of 5-methyl-1-phenyl-2-(1h)-pyridone

Country Status (5)

Country Link
JP (1) JPS51128437A (en)
AU (1) AU508824B2 (en)
DK (1) DK555875A (en)
GB (1) GB1529960A (en)
ZA (1) ZA757570B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU633541B2 (en) * 1989-02-15 1993-02-04 Kdl Gmbh Composition for reparation and prevention of fibrotic lesions

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08510251A (en) * 1993-05-07 1996-10-29 ビー マーゴリン、ソロモン Compositions and methods for repair and prevention of fibrotic lesions
JP4542743B2 (en) * 2002-12-26 2010-09-15 Kdl株式会社 Solution pharmaceutical composition of pyridone derivatives
ES2600460T3 (en) * 2005-05-10 2017-02-09 Intermune, Inc. Pyridone-2-one derivatives as modulators of the stress-activated protein kinase system
MX2007009796A (en) * 2007-08-14 2009-02-25 Cell Therapy And Technology S Gel containing pirfenidone.
US10105356B2 (en) 2011-01-31 2018-10-23 Avalyn Pharma Inc. Aerosol pirfenidone and pyridone analog compounds and uses thereof
WO2012106382A1 (en) 2011-01-31 2012-08-09 Genoa Pharmaceuticals, Inc. Aerosol pirfenidone and pyridone analog compounds and uses thereof
US12226407B2 (en) 2012-07-24 2025-02-18 Avalyn Pharma Inc. Aerosol pirfenidone and pyridone analog compounds and uses thereof
EP2877164B1 (en) 2012-07-24 2023-07-05 Avalyn Pharma Inc. Aerosol pirfenidone and pyridone analog compounds
AU2015204558B2 (en) 2014-01-10 2020-04-30 Avalyn Pharma Inc. Aerosol pirfenidone and pyridone analog compounds and uses thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU633541B2 (en) * 1989-02-15 1993-02-04 Kdl Gmbh Composition for reparation and prevention of fibrotic lesions

Also Published As

Publication number Publication date
AU8738375A (en) 1977-06-16
GB1529960A (en) 1978-10-25
JPS51128437A (en) 1976-11-09
ZA757570B (en) 1977-07-27
DK555875A (en) 1976-06-10

Similar Documents

Publication Publication Date Title
IL47084A0 (en) Derivatives of pyridine
AU502752B2 (en) Pyridines
AU506351B2 (en) Picolinic acid derivatives
AU508824B2 (en) Adminstration of 5-methyl-1-phenyl-2-(1h)-pyridone
AU506001B2 (en) Substituted benzamides
JPS5219675A (en) 33iminoalkyll2*1h**pyridines preparation method and komposite thereof
AU500419B2 (en) Preparation of 3-phenoxybenzaldehydes
HK46681A (en) 3-(alpha-iminobenzyl)-4-hydroxy-6-phenyl-1-methyl-2(1h)-pyridone
AU509813B2 (en) Preparation of triazine-diones
JPS51128973A (en) Preparation method of aminopyridine
SU583362A1 (en) Furan-3-carbon amides of alpha-asparaginazes exhibiting antileukosis activity
SU600089A1 (en) Method of preparing dioxytetrachlormolybdates
AU476488B2 (en) Preparation of 6-deoxytetracyclines
AU518493B2 (en) Nicotinic derivatives of estriol
CA1028709A (en) 6-hydrazino-2,3,5-trihalo-4-alkylthio pyridines and method of preparing same
AU493262B2 (en) New derivatives of pyridine
AU4952679A (en) 3-(alpha-iminobenzyl)-4-hydroxy-6-phenyl-1-methyl-2(1h)- pyridone
JPS527968A (en) 33phenyll4*1h*pyridone and pyridinthiones and salts thereof
AU491667B2 (en) Quinoline derivatives
NZ185126A (en) 3-( -iminobenzyl)-4-hydroxy-6-phenyl-1-methyl-2(1h)-pyridone and pharmaceutical compositions
EG11860A (en) Preparation of novel substituted pyridines
AU471466B2 (en) Penam compounds and preparation thereof
AU1392276A (en) Compounds for controlling coccidiosis and their preparation
AU482252B2 (en) 2-HYDROXYMETHYL-3-HYDROXY-6-(1-HYDROXY-2-t BUTYLAMINOETHYL) PYRIDINE PREPARATION AND INTERMEDIATE COMPOUNDS
CA1026743A (en) Oxidation products of vinylfurans